Compare AU

Compare EYE vs. A200

Compare shares and ETFs on the ASX that you can trade on Pearler.

Nova EYE Medical Limited

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are EYE and A200. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

EYE

A200

Popularity

Low

Medium

Pearlers invested

5

4,884

Median incremental investment

$693.50

$1,076.78

Median investment frequency

Weekly

Monthly

Median total investment

$507.30

$3,642.60

Average age group

26 - 35

26 - 35


Key Summary

EYE

A200

Strategy

N/A

BetaShares Australia 200 ETF (ASX: A200) seeks to track the performance of the Solactive Australia 200 index before account fees, expenses, and taxes. The index tracks the largest 200 companies on the Australian Securities Exchange (ASX).

Top 3 holdings

Nova EYE Medical Limited (100 %)

COMMONWEALTH BANK OF AUSTRALIA (10.89 %)

BHP GROUP LTD (8.16 %)

CSL LTD (5.53 %)

Top 3 industries

Health Care (100 %)

Financials (34.23 %)

Materials (17.97 %)

Health Care (8.44 %)

Top 3 countries

Australia (100 %)

Australia (95.07 %)

United States (3.04 %)

New Zealand (1.41 %)

Management fee

N/A

0.04 %


Key Summary

EYE

A200

Issuer

N/A

BetaShares

Tracking index

N/A

Solactive Australia 200 Index - AUD

Asset class

Stock

ETF

Management fee

N/A

0.04 %

Price

$0.15

$140.89

Size

$35.504 million

$6.258 billion

10Y return

-9.30 %

N/A

Annual dividend/ distribution yield (5Y)

9.89 %

5.25 %

Market

ASX

ASX

First listed date

11/09/1994

08/05/2018

Purchase fee

$6.50

$6.50


Community Stats

EYE

A200

Popularity

Low

Medium

Pearlers invested

5

4,884

Median incremental investment

$693.50

$1,076.78

Median investment frequency

Weekly

Monthly

Median total investment

$507.30

$3,642.60

Average age group

26 - 35

26 - 35


Pros and Cons

EYE

A200

Pros

  • Higher dividend/distribution yield

  • Exposure to more markets and sectors

  • Higher price growth

Cons

  • Exposure to 1 market and 1 sector only

  • Lower price growth

  • Lower dividend/distribution yield

EYE

A200

Exposure to 1 market and 1 sector only

Exposure to more markets and sectors

Lower price growth

Higher price growth

Higher dividend/distribution yield

Lower dividend/distribution yield

Home